Nucleoside transporter proteins: Emerging targets for drug discovery

Expert Opinion on Therapeutic Targets

Volumn 4, Issue 4, 2000, Pages 515-539

  Vickers, Mark F ^a,b   Young, James D ^a   Baldwin, Stephen A ^c   MacKey, John R ^a,b   Cass, Carol E ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

adenosine; antimetabolites; antiviral chemotherapy; cancer chemotherapy; membrane transporter proteins; nucleoside transport; nucleotide metabolism; parasitic disease; purinergic receptors; uridine

Indexed keywords

EID: 0000159702     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.4.4.515     Document Type: Review

References (85)

1. CASS CE, YOUNG JD, BALDWIN SA et al: Nucleoside transporters of mammalian cells. In: Membrane Transporters as Drug Targets. Amidon GL, Sadee W (Eds.), Kluwer Academic/Plenum Publishers (1999).
2. CASS CE, YOUNG JD, BALDWIN SA: Recent advances in the molecular biology of nucleoside transporters of mammalian cells. Biochem. Cell. Biol. (1998) 76 (5):761-770.
3. GRIFFITH DA, JARVIS SM: Nucleoside and nucleobase transport systems of mammalian cells. Biochim. Biophys. Acta (1996) 1286 (3):153-181.
4. CASS CE: Nucleoside transport. In: Drug Transport in Antimicrobial and AntiCancer Chemotherapy. Georgopa-padakou NH (Ed.), Marcel Deker, New York, USA (1995):403-451.
5. MACKEY JR, MANI RS, SELNER M et al.: Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res. (1998) 58(19)4349-4357.
6. BALDWIN SA, MACKEY JR, CASS CE, YOUNG JD: Nucleo side transporters: molecular biology and implications for therapeutic development. Mol. Med. Today (1999) 5 (5):216-224.
7. MANI RS, HAMMOND JR, MARJAN JM et al.: Demonstration of equilibrative nucleoside transporters (hENT1 and hENT2) in nuclear envelopes of cultured human choriocarcinoma (BeWo) cells by functional reconsti-tution in proteoliposomes. J. Biol. Chem. (1998) 273 (46):30818-30825.
8. PISONI RL, THOENE JG: Detection and characterization of a nucleoside transport system in human fibroblast lysosomes. J. Biol. Chem. (1989) 264(9):4850-4856.
9. CAMINS A, JIMENEZ A, SUREDA FX et al.: Characterization of nitrobenzylthioinosine binding sites in the mitochondrial fraction of rat testis. Life Sci. (1996) 58 (9):753-759.
10. JIMENEZ A, PUBILL D, PALLAS M et al.: Further characterization of an adenosine transport system in the mitochondrial fraction of rat testis. Eur. J. Pharmacol (2000) 398 (1):31-39.
11. FLANAGAN SA, MECKLING-GILL KA: Characterization of a novel Na+-dependent, guanosine-specific, nitrobenzylthioinosine-sensitive transporter in acute promyelocytic leukemia cells. J. Biol. Chem. (1997) 272 (29):18026-18032.
12. WANG J, SCHANER ME, THOMASSEN S et al: Functional and molecular characteristics of Na(+)-dependent nucleoside transporters. Pharmacol. Res. (1997) 14(11):1524-1532.
13. HUANG QQ, YAO SY, RITZEL MW et al: Cloning and functional expression of a complementary DNA encoding a mammalian nucleoside transport protein. J. Biol. Chem. (1994) 269 (27):17757-17760.
14. YAO SY, NG AM, RITZEL MW et al.: Transport of adenosine by recombinant purine-and pyrimidine-selective sodium/nucleoside cotransporters from rat jejunum expressed in Xenopus laevis oocytes. Mol. Pharmacol. (1996) 50 (6):1529-1535.
15. CHE M, ORTIZ DF, ARIAS IM: Primary structure and functional expression of a cDNA encoding the bile canalicular, purine-specific Na(+)-nucleoside cotrans-porter. J. Biol. Chem. (1995) 270(23):13596-13599.
16. RITZEL MW, YAO SY, HUANG MY et al.: Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1). Am. J. Physiol. (1997) 272(2 Pt 1):C707-C714.
17. YAO SY, NG AM, MUZYKA WR et al.: Molecular cloning and functional characterization of nitrobenzylthioi-nosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J.Biol. Chem. (1997) 272 (45):28423-28430.
18. RITZEL MW, YAO SY, NG AM et al: Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotrans-porter (hCNT2) selective for purine nucleosides and uridine. Mol. Membr. Biol. (1998) 15 (4):203-211.
19. GRIFFITHS M, BEAUMONT N, YAO SY et al: Cloning of a human nucleoside transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs. Nature Med. (1997) 3 (1):89-93.
20. GRIFFITHS M, YAO SY, ABIDI F et al.: Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placenta. Biochem. J. (1997) 328 (Pt 3):739-743.
21. WANG J, SU SF, DRESSER MJ et al: Na(+)-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am. J. Physiol (1997) 273(6 Pt 2):F1058-F1065.
22. CRAWFORD CR, PATEL DH, NAEVE C, BELT JA: Cloning of the human equilibrative, nitrobenzylmercaptopu-rine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line. J. Biol. Chem. (1998) 273 (9):5288-5293.
23. PAJOR AM: Sequence of a pyrimidine-selective Na+/nucleoside cotransporter from pig kidney, pkCNT1. Biochim. Biophys. Acta (1998) 1415(1):266-269.
24. PATEL DH, CRAWFORD CR, NAEVE CW, BELT JA: Cloning, genomic organization and chromosomal localization of the gene encoding the murine sodium-dependent,purine-selective, concentrativenucleoside transporter (CNT2). Gene (2000) 242(1-2):51-58.
25. HUANG QQ, HARVEY CM, PATERSON AR, CASS CE, YOUNG JD: Functional expression of Na(+)-dependent nucleoside transport systems of rat intestine in isolated oocytes of Xenopus laevis. Demonstration that rat jejunum expresses the purine-selective system N1 (cif) and a second, novel system N3 having broad specificity for purine and pyrimidine nucleosides. J. Biol. Chem. (1993) 268(27):20613-20619.
26. FELIPE A, VALDES R, SANTO B et al.: Na+-dependent nucleoside transport in liver: two different isoforms from the same gene family are expressed in liver cells. Biochem. J. (1998) 330(Pt 2):997-1001.
27. ANDERSON CM, XIONG W, YOUNG JD, CASS CE, PARKINSON FE: Demonstration of the existence of mRNAs encoding N1/cif and N2/cit sodium/nucleo-side cotransporters in rat brain. Brain Res. Mol. Brain Res. (1996) 42(2):358-361.
28. YAO SY, CASS CE, YOUNG JD: Transport of the antiviral nucleoside analogs 3′-azido-3′-deoxythymidine and 2′,3′-dideoxycytidine by a recombinant nucleoside transporter (rCNT) expressed in Xenopus laevis oocytes. Mol. Pharmacol. (1996) 50(2):388-393.
29. WANG J, GIACOMINI KM: Molecular determinants of substrate selectivity in Na+-dependent nucleoside transporters. J. Biol. Chem. (1997) 272(46):28845-28848.
30. FANG X, PARKINSON FE, MOWLES DA, YOUNG JD, CASS CE: Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells. Biochem. J. (1996) 317(Pt 2):457-465.
31. LOEWEN SK, NG AM, YAO SY et al.: Identification of amino acid residues responsible for the pyrimidine and purine nucleoside specificities of human concen-trative Na(+) nucleoside cotransporters hCNT1 and hCNT2. J. Biol. Chem. (1999) 274(35):24475-24484.
32. WANG J, GIACOMINI KM: Serine 318 is essential for the pyrimidine selectivity of the N2 Na+-nucleoside transporter. J. Biol. Chem. (1999) 274(4):2298-2302.
33. KWONG FY, DAVIES A, TSE CM et al.: Purification of the human erythrocyte nucleoside transporter by immunoaffinity chromatography. Biochem. J. (1988) 255(1):243-249.
34. BOLETI H, COE IR, BALDWIN SA, YOUNG JD, CASS CE: Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells. Neuropharmacology (1997) 36(9):1167-1179.
35. COE IR, GRIFFITHS M, YOUNG JD, BALDWIN SA, CASS CE: Assignment of the human equilibrative nucleoside transporter (hENT1) to 6p21.1-p21.2. Genomics (1997) 45(2):459-460.
36. SUNDARAM M, YAO SYM, NG AML et al.: Chimeric constructs between human and rat equilibrative nucleoside transporters (hENT1 and rENT1) reveal hENT1 structural domains interacting with coronary vasoactive drugs. J. Biol. Chem. (1998) 273(34):21519-21525.
37. PATERSON AR, GATI WP, VIJAYALAKSHMI D et al.: Inhibitor-sensitive, Na(+)-linked transport of nucleo-side analogs in leukemia cells from patients (meeting abstract). Proc. Ann. Meet. Am. Assoc. Cancer Res. (1993) 34:A84.
38. BELT JA, MARINA NM, PHELPS DA, CRAWFORD CR: Nucleoside transport in normal and neoplastic cells. Adv. Enzyme Regul. (1993) 33:235-252.
39. BERENS RL, KRUG EC, MARR JJ: Biochemistry and Molecular Biology of Parasites. Marr JJ, Muller M (Eds.) Academic Press, Inc., New York, USA (1995):89-117.
40. VASUDEVAN G, CARTER NS, DREW ME et al.: Cloning of Leishmania nucleoside transporter genes by rescue of a transport-deficient mutant. Proc. Natl. Acad. Sci. USA (1998) 95(17):9873-9878.
41. CARTER NS, DREW ME, SANCHEZ M et al.: Cloning of a novel inosine-guanosine transporter gene from Leishmania donovani by functional rescue of a transport-deficient mutant. J. Biol. Chem. (2000) 275:20935-20941.
42. MASER P, SUTTERLIN C, KRALLI A, KAMINSKY R: A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science (1999) 285(5425):242-244.
43. SANCHEZ MA, ULLMAN B, LANDFEAR SM, CARTER NS: Cloning and functional expression of a gene encoding a P1 type nucleoside transporter from Trypanosoma brucei. J. Biol. Chem. (1999) 274(42):30244-30249.
44. SCHWAB JC, AFIFI AFIFI M, PIZZORNO G, HANDSCHU-MACHER RE, JOINER KA: Toxoplasma gondii tachyzoi-tes possess an unusual plasma membrane adenosine transporter. Mol. Biochem. Parasitol. (1995) 70(1-2):59-69.
45. CHIANG CW, CARTER N, SULLIVAN WJ, JR. et al.: The adenosine transporter of Toxoplasma gondii. Identification By insertional mutagenesis, cloning and recombinant expression. J. Biol. Chem. (1999) 274(49):35255-35261.
46. CARTER NS, BEN MAMOUN C, LIU W et al.: Isolation and functional characterization of the PfNT1 nucleoside transporter gene from Plasmodium falciparum. J. Biol. Chem. (2000) 275(14):10683-10691.
47. PARKER MD, HYDE RJ, YAO SY et al.: Identification of a nucleoside/nucleobase transporter fromPlasmodium falciparum, a novel target for anti-malarial chemotherapy. Biochem. J. (2000) 349(Pt 1):67-75.
48. RAO TV, VERMA RS, PRASAD R: Transport of purine, pyrimidine bases and nucleosides in Candida albicans, a pathogenic yeast. Biochem. Int. (1983) 6(3):409-417.
49. FASOLI MO AND KERRIDGE D: Uptake of pyrimidines and their derivatives into Candida glabrata and Candida albicans. J. Gen. Microbiol. (1990) 136(Pt 8):1475-1481.
50. FASOLI MO, KERRIDGE D, MORRIS PG, TOROSANTUCCI A: 19F nuclear magnetic resonance study of fluoropy-rimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism. Antimicrob. Agents Chemother. (1990) 34(10):1996-2006.
51. DETKE S: Cloning of the Candida albicans nucleoside transporter by complementation of nucleoside transport-deficient Saccharomyces. Yeast (1998) 14(14):1257-1265.
52. GRENSON M: The utilization ofexogenous pyrimidines and the recycling of uridine-5′-phosphate derivatives in Saccharomyces cerevisiae, as studied by means of mutants affected in pyrimidine uptake and metabolism. Eur. J. Biochem. (1969) 11(2):249-260.
53. JUND R, LACROUTE F: Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae. J. Bacteriol. (1970) 102(3):607-615.
54. NELISSEN B, MORDANT P, JONNIAUX JL, DE WACHTER R, GOFFEAU A: Phylogenetic classification of the major superfamily of membrane transport facilitators, as deduced from yeast genome sequencing. FEBS Lett. (1995) 377(2):232-236.
55. NELISSEN B, DE WACHTER R, GOFFEAU A: Classification of all putative permeases and other membrane pluris-panners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae. FEMS Microbiol. Rev. (1997) 21(2):113-134.
56. WAGNER R, DE MONTIGNY J, DE WERGIFOSSE P, SOUCIET JL, POTIER S: The ORF YBL042 of Saccharo-myces cerevisiae encodes a uridine permease. FEMS Microbiol. Lett. (1998) 159(1):69-75.
57. VICKERS MF, YAO SYM, BALDWIN SA, YOUNG JD, CASS CE: Nucleoside transporter proteins of Saccharo-myces cerevisiae: demonstration of a transporter (FUI1) with high uridine selectivity in plasma membranes and a transporter (FUN26) with broad nucleoside selectivity in intracellular membranes. J. Biol. Chem. (2000) (In Press).
58. BARTON AB, KABACK DB: Molecular cloning of chromosome I DNA from Saccharomyces cerevisiae: analysis of the genes in the FUN38-MAK16-SPO7 region. J. Bacteriol. (1994) 176(7):1872-1880.
59. CRAIG JE, ZHANG Y, GALLAGHER MP: Cloning of the nupC gene of Escherichia coli encoding a nucleoside transport system and identification of an adjacent insertion element, IS 186. Mol. Microbiol. (1994) 11 (6):1159-1168.
60. WESTH HANSEN SE, JENSEN N, MUNCH-PETERSEN A: Studies on the sequence and structure of the Escherichia coli K-12 nupG gene, encoding a nucleoside-transport system. Eur. J. Biochem. (1987) 168 (2):385-391.
61. YAO SYM: Intestinal nucleoside and amino acid transport. In: Physiology. Edmonton, University of Alberta (1995):236.
62. MUNCH-PETERSEN A, JENSEN N: Analysis of the regula tory region of the Escherichia coli nupG gene, encoding a nucleoside-transport protein. Eur. J. Biochem. (1990) 190 (3):547-551.
63. MACKEY JR, BALDWIN SA, YOUNG JD, CASS CE: Nucleo side transport and its significance for anticancer drug resistance. Drug Resist. Updates (1998) 1:310-324.
64. SCHANER ME, GERSTIN KM, WANG J, GIACOMINI KM: Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus. Adv. DrugDeliv. Rev. (1999) 39 (1-3):51-62.
65. ARONOW B, ULLMAN B: Thymidine incorporation in nucleoside transport-deficient lymphoma cells. J. Biol. Chem. (1985) 260 (30):16274-16278.
66. CASS CE, KOLASSA N, UEHARA Y et al.: Absence of binding sites for the transport inhibitor nitrobenzyl-thioinosine on nucleoside transport-deficient mouse lymphoma cells. Biochim. Biophys. Acta (1981) 649 (3):769-777.
67. COHEN A, ULLMAN B, MARTIN DW, JR.: Characterization of a mutant mouse lymphoma cell with deficient transport of purine and pyrimidine nucleosides. J. Biol. Chem. (1979) 254 (1):112-116.
68. ULLMAN B, COONS T, ROCKWELL S, MCCARTAN K: Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human Tlymphoblasts. J. Biol. Chem. (1988) 263 (25):12391-12396.
69. ULLMAN B: Dideoxycytidine metabolism in wild type and mutant CEM cells deficient in nucleoside transport or deoxycytidine kinase. Adv. Exp. Med. Biol. (1989) 293B:415-20.
70. 2) levels. Invest. New Drugs (1997) 15 (2):115-121.
71. WANG J AND GIACOMINI KM: Characterization of a bioengineered chimeric Na+-nucleoside transporter. Mol. Pharmacol. (1999) 55(2):234-240.
72. MACKEY JR, YAO SY, SMITH KM et al.: Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters.J. Natl. Cancer Inst. (1999) 91 (21):1876-1881.
73. SCHANER ME, WANG J, ZEVIN S, GERSTIN KM, GIACOMINI KM: Transient expression of a purine-selective nucleoside transporter (SPNTint)in a human cell line (HeLa). Pharmacol. Res.(1997) 14(10):1316-1321.
74. CRAWFORD CR, CASS CE, YOUNG JD, BELT JA: Stable expression of a recombinant sodium-dependent, pyrimidine-selective nucleoside transporter (CNT1) in a transport-deficient mouse leukemia cell line. Biochem. Cell. Biol. (1998) 76(5):843-851.
75. SCHANER ME, WANG J, ZHANG L et al.: Functional characterization of a human purine-selective, Na+-dependent nucleoside transporter (hSPNT1) in a mammalian expression system. J. Pharmacol. Exp. Ther. (1999) 289(3):1487-1491.
76. WARD JL, SHERALI A, MO ZP, TSE CM: Kinetic and pharmacological properties of cloned human equili-brative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J. Biol. Chem. (2000) 275(12):8375-8381.
77. SEKLER I, KOPITO R, CASEY JR: High level expression, partial purification and functional reconstitution of the human AE1 anion exchanger in Saccharomyces cerevisiae. J. Biol. Chem. (1995) 270(36):21028-21034.
78. RUETZ S, GROS P: Functional expression of P-glycoproteins in secretory vesicles. J. Biol. Chem. (1994) 269(16):12277-12284.
79. VICKERS MF, MANI RS, SUNDARAM M et al.: Functional production and reconstitutionofthehuman equilibra-tive nucleoside transporter (hENT1) in Saccharo-myces cerevisiae. Interaction of inhibitors of nucleoside transport with recombinant hENT1 and a glycosylation-defective derivative (hENT1/N48Q). Biochem. J. (1999) 339(Pt 1):21-32.
80. AUSUBEL FM, BRENT R, KINGSTON RE et al.: Current protocols in molecular biology. In: Current Protocols. Chanda VB (Ed.), John Wiley & Sons, Inc., New York, USA (1997).
81. HOGUE DL, ELLISON MJ, YOUNG JD, CASS CE: Identification of a novel membrane transporter associated with intracellular membranes by phenotypic complementation in the yeast Saccharomyces cerevisiae. J. Biol. Chem. (1996) 271(16):9801-9808.
82. HOGUE DL, ELLISON MJ, VICKERS M, CASS CE: Functional complementation of a membrane transport deficiency in Saccharomyces cerevisiae by recombinantND4 fusionprotein. Biochem. Biophys. Res. Commun. (1997) 238(3):811-816.
83. GUITERREZ MM, BRETT CM, OTT RJ, HUI AC, GIACOMINI KM: Nucleoside transport in brush border membrane vesicles from human kidney. Biochem. Biophys. Acta (1992) 1105(1):1-9.
84. GUITERREZ MM, GIACOMINI KM: Substrate selectivity, potential sensitivity and stoichiometry of Na+-nucle-oside transport in brush border membranes from human kidney. Biochem. Biophys. Acta (1993) 1149(2):202-208.
85. ANDERSON CM, BALDWIN SA, YOUNG JD, CASS CE, PARKINSON FE: Distribution of mRNA encoding a nitrobenzyltioinosine-insensitive nucleoside transporter (ENT2) in rat brain. Brain Res. Mol. Brain Res. (1999) 70(2):293-297.